130 related articles for article (PubMed ID: 27178387)
1. Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine.
Zhao N; Tian KT; Cheng KG; Han T; Hu X; Li DH; Li ZL; Hua HM
Bioorg Med Chem; 2016 Jul; 24(13):2971-2978. PubMed ID: 27178387
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties.
Hu X; Jiao R; Li H; Wang X; Lyu H; Gao X; Xu F; Li Z; Hua H; Li D
Eur J Med Chem; 2018 May; 151():376-388. PubMed ID: 29635169
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents.
Tian K; Xu F; Gao X; Han T; Li J; Pan H; Zang L; Li D; Li Z; Uchita T; Gao M; Hua H
Eur J Med Chem; 2017 Aug; 136():131-143. PubMed ID: 28494251
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J
Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
Hu X; Wang Y; Xue J; Han T; Jiao R; Li Z; Liu W; Xu F; Hua H; Li D
Bioorg Med Chem Lett; 2017 Nov; 27(22):4989-4993. PubMed ID: 29037951
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-donating derivatives of hederacolchiside A
Fang Y; Wang R; He M; Huang H; Wang Q; Yang Z; Li Y; Yang S; Jin Y
Bioorg Med Chem Lett; 2017 Jan; 27(1):98-101. PubMed ID: 27866816
[TBL] [Abstract][Full Text] [Related]
7. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway.
Han T; Wang Y; Wang M; Li X; Cheng K; Gao X; Li Z; Bai J; Hua H; Li D
Eur J Med Chem; 2018 Oct; 158():493-501. PubMed ID: 30243153
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP.
Kan SF; Huang WJ; Lin LC; Wang PS
Int J Cancer; 2004 Jul; 110(5):641-51. PubMed ID: 15146552
[TBL] [Abstract][Full Text] [Related]
10. Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer.
Li D; Han T; Tian K; Tang S; Xu S; Hu X; Wang L; Li Z; Hua H; Xu J
Bioorg Med Chem Lett; 2016 Sep; 26(17):4191-6. PubMed ID: 27491707
[TBL] [Abstract][Full Text] [Related]
11. NO-Releasing Enmein-Type Diterpenoid Derivatives with Selective Antiproliferative Activity and Effects on Apoptosis-Related Proteins.
Li D; Hu X; Han T; Liao J; Xiao W; Xu S; Li Z; Wang Z; Hua H; Xu J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617998
[TBL] [Abstract][Full Text] [Related]
12. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities.
Abdelbaset MS; Abdel-Aziz M; Abuo-Rahma GEA; Abdelrahman MH; Ramadan M; Youssif BGM
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800270. PubMed ID: 30500087
[TBL] [Abstract][Full Text] [Related]
13. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy.
Rasul A; Yu B; Zhong L; Khan M; Yang H; Ma T
Oncol Rep; 2012 May; 27(5):1481-7. PubMed ID: 22367117
[TBL] [Abstract][Full Text] [Related]
15. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
[TBL] [Abstract][Full Text] [Related]
16. Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation.
Han T; Li J; Xue J; Li H; Xu F; Cheng K; Li D; Li Z; Gao M; Hua H
Eur J Med Chem; 2017 Jul; 135():270-281. PubMed ID: 28458133
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biological Activity, and Apoptotic Properties of NO-Donor/Enmein-Type ent-Kauranoid Hybrids.
Li D; Hu X; Han T; Xu S; Zhou T; Wang Z; Cheng K; Li Z; Hua H; Xiao W; Xu J
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231893
[TBL] [Abstract][Full Text] [Related]
18. Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes.
Huang YC; Guh JH; Teng CM
Life Sci; 2004 May; 75(1):35-49. PubMed ID: 15102520
[TBL] [Abstract][Full Text] [Related]
19. Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents.
Luan T; Cao LH; Deng H; Shen QK; Tian YS; Quan ZS
Molecules; 2018 Dec; 24(1):. PubMed ID: 30598028
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and induction of apoptosis in SGC‑7901 human gastric cancer cells by evodiamine.
Yang L; Liu X; Wu D; Zhang M; Ran G; Bi Y; Huang H
Mol Med Rep; 2014 Apr; 9(4):1147-52. PubMed ID: 24481835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
